Aculys Pharma joins the Sleep Services Consortium of Japan
As a venture to establish a new pharmaceutical model, supports the efforts to address sleep issues across industry boundaries. Tokyo, Japan, March2, 2023 — Aculys Pharma, Inc. (“Aculys”), a clinical stage biopharmaceutical company focused on commercializing innovative treatments for neurological conditions announced today that it joined the Sleep Services Consortium. The Consortium is Japan’s organization bringing together sleep-related businesses, government, and academia. With the Sleep Services Consortium, Aculys plans to provide knowledge and research results in sleep disorders to advance the field. The Sleep Services Consortium was established in February 2020 with the aim of realising a society in which consumers can